EN DE

Kriti Nutrients Limited (KRITINUT) Fair Value & Analysis

Consumer Defensive · IN · Market cap ₹4.2B

KN Kriti Nutrients Limited KRITINUT · NSE
Price₹85.15
Fair Value₹122.70
Upside+44.1%
Quality65/100
Watch Kriti Nutrients Limited for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 3.7% net margin
generates free cash flow
Ranks above peers (10/13)
Narrow moat 41/100
Evidence: High Range ₹94.53 – ₹150.88 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated 4 days ago

Share price +10.8% over the past month.

A solid business, screening 44% undervalued on our models.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price is below even our cautious bear case (₹94.53). The market is more pessimistic than our downside scenario.
  • Solid quality (65/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

₹153.13 ₹36.43 Fair Value ₹122.70 Oct 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

46‑month range ₹36.43 – ₹153.13 · fair‑value band ₹94.53 – ₹150.88 · the ₹85.15 price screens below the ₹122.70 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Kriti Nutrients Limited (KRITINUT) currently trades at ₹85.15, while our model-based Fair Value estimate is ₹122.70, implying the stock looks roughly 44.1% undervalued today. The Quality Score stands at 65/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Kriti Nutrients Limited generated revenue of ₹9.2B at a net margin of 3.7%. Revenue grew 27.6% year over year. It earns a return on equity of 15.4%. The balance sheet holds a net cash position of ₹501M. Fundamentals as of Aug 13, 2026

Our scenario range runs from ₹94.53 (bear case) to ₹150.88 (bull case); at ₹85.15, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high and 66% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at 44%, KRITINUT screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income ₹44.82 ₹56.12 ₹123.86 76
Growth DCF ₹156.41 ₹238.67 ₹362.06 72
Gordon GGM ₹28.74 ₹57.26 ₹86.71 70
All 26 models by family
DCF Models
FCF DCF ₹155.40 ₹240.30 ₹369.65 38
Owner Earnings ₹87.96 ₹132.98 ₹201.57 31
5Y Revenue Exit ₹105.10 ₹151.46 ₹209.82 39
5Y EBITDA Exit ₹111.59 ₹163.95 ₹224.80 41
5Y P/E Exit ₹124.38 ₹188.56 ₹256.80 38
10Y Revenue Exit ₹120.15 ₹167.24 ₹230.00 36
10Y EBITDA Exit ₹126.31 ₹175.85 ₹241.49 37
10Y P/E Exit ₹134.37 ₹192.81 ₹266.01 35
Earnings-Based
Graham-Dodd ₹46.01 ₹163.68 ₹220.40 54
Lynch FV ₹38.46 ₹54.94 ₹71.42 50
PEG = 1.0 ₹38.46 ₹54.94 ₹71.42 46
EPV ₹59.75 ₹67.32 ₹73.85 59
Dividend Discount
Gordon GGM ₹28.74 ₹57.26 ₹86.71 70
DDM Multi-Stage ₹28.74 ₹49.49 ₹60.44 61
Multiples
P/E Multiple ₹106.57 ₹142.09 ₹177.61 63
P/S Multiple ₹86.27 ₹115.03 ₹143.78 58
P/B Multiple ₹86.27 ₹115.03 ₹143.78 55
EV/EBIT ₹107.72 ₹139.69 ₹171.66 53
EV/EBITDA ₹96.34 ₹124.52 ₹152.70 54
EV/Revenue ₹80.27 ₹109.60 ₹138.94 43
Asset-Based
NCAV (Graham) ₹22.87 ₹30.64 ₹45.73 50
Growth DCF
Growth DCF ₹156.41 ₹238.67 ₹362.06 72
Rev-Margin DCF ₹105.10 ₹152.58 ₹209.71 67
Economic Profit
Residual Income ₹44.82 ₹56.12 ₹123.86 76
ROIC Compounder ₹63.27 ₹78.03 ₹96.54 67
Growth Earnings
Growth-Adj P/E ₹73.94 ₹105.62 ₹137.31 68

Widest divergence: DCF Models (₹167.24) versus Asset-Based (₹30.64). Highest evidence: Residual Income (76).

Notify me when KRITINUT reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) ₹9.2B
Revenue growth (YoY) +27.6%
Net margin 3.7%
Return on equity 15.4%
Free cash flow ₹643M FY2026
P/E ratio 12.6
More key figures
Operating margin 3.1%
EPS (TTM) ₹6.77
EPS growth (YoY) +28.3%
Net cash ₹501M FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 65/100

Of which business quality 69 · Market factors (momentum, volatility) 41

Profitability 61
Margins and returns on capital today
Quality Growth 48
Are margins and returns improving?
Cashflow 68
Earnings quality: real cash, not paper profit
Fin. Strength 94
Balance sheet, leverage, solvency risk
Investment 46
Disciplined investing over empire-building
Low Volatility 49
Calm price path (market factor)
Momentum 38
Price trend over the last 3–12 months (market factor)
52W Momentum 38
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Kriti Nutrients Limited manufactures and sells soya-based products under the Kriti brand in India and internationally. It provides edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya lecithin; protein-based nuggets/TVP, full fat soya flour, defatted flakes/ grits/ flour toasted, defatted flakes/ grits/ …

Full company description

Kriti Nutrients Limited manufactures and sells soya-based products under the Kriti brand in India and internationally. It provides edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya lecithin; protein-based nuggets/TVP, full fat soya flour, defatted flakes/ grits/ flour toasted, defatted flakes/ grits/ flour untoasted, super HyPro SBM, and soya hulls; and acid oil and fatty acids. It serves food, pharmaceutical, aqua and poultry, infant, and dairy industries. The company was founded in 1992 and is based in Indore, India. Kriti Nutrients Limited is a subsidiary of Sakam Trading Private Limited.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Kriti Nutrients Limited reported revenue of ₹9.2B in FY2026 versus ₹7.5B in FY2022, a compound +5.2%/yr. Reported net income was ₹339M in FY2026, compounding +28.8%/yr from FY2022.

Growth Quality 71/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹9.2B
Latest YoY
+25.5%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.0%
Avg. growth/yr (15Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.9%
Revenue +5.2%/yr
FY22 ₹7.5B
FY23 ₹8.0B
FY24 ₹6.8B
FY25 ₹7.3B
FY26 ₹9.2B
Net income +28.8%/yr
FY22 ₹123M
FY23 ₹208M
FY24 ₹453M
FY25 ₹370M
FY26 ₹339M
Character of growth · EPS growth decomposed (2015-2026) +22.8 % p.a.
Revenue per share +8.5 pp

of which total revenue +8.5 pp · buybacks/dilution +0.0 pp

EBIT margin +9.5 pp
Tax rate +1.3 pp
Residual (interest, one-offs) +3.5 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch KRITINUT: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Kriti Nutrients Limited Fair Value". https://www.fairvalue-calculator.com/stock/KRITINUT

Peer Group

Packaged Foods · 651 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 65 · Top 25%
Fair Value upside +44% · Top 25%
Return on equity (TTM) 15% · Top 25%
Return on assets 9% · Top 25%
Net margin (TTM) 4% · Above median
Operating margin (TTM) 3% · Below median
Revenue growth 28% · Top 25%
Dividend yield (TTM) 3.9% · Above median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 12.6× · Cheaper than median
P/B 1.82× · Pricier than median
P/S (TTM) 0.45× · Cheaper than median
P/FCF 0.1× · Cheaper than 75% of peers
EV/EBITDA 8.2× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 92 · sector 25
FUTURE 100 · sector 20
PAST 61 · sector 28
HEALTH 0 · sector 96
DIVIDEND 79 · sector 55

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,507 ₹362.37 -76%
Britannia Industries Limited BRITANNIA ₹5,646 ₹1,870 -67%
Tata Consumer Products Limited TATACONSUM ₹1,062 ₹327.27 -69%
PT Indofood CBP Sukses Makmur Tbk ICBP 7,550 IDR 12,864 IDR +70%
Samyang Foods Co 003230 1,219,000 KRW 1,010,543 KRW -17%
Patanjali Foods Limited PATANJALI ₹352.60 ₹144.77 -59%
Vietnam Dairy Products Joint Stock Company VNM 61,600 VND 52,858 VND -14%
PT Mayora Indah Tbk, MYOR 1,665 IDR 2,699 IDR +62%
PT Cisarua Mountain Dairy Tbk CMRY 4,630 IDR 4,350 IDR -6%
Nongshim Co 004370 389,500 KRW 530,619 KRW +36%

Compare Kriti Nutrients Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Kriti Nutrients Limited (KRITINUT) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of ₹122.70 versus a price of ₹85.15, about +44% (undervalued).
What is the fair value of KRITINUT?
Our model-based fair value for Kriti Nutrients Limited is ₹122.70 (as of Aug 13, 2026), built from audited fundamentals. The current price is ₹85.15.
What is the quality score of KRITINUT?
Kriti Nutrients Limited has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Kriti Nutrients Limited (KRITINUT)?
Kriti Nutrients Limited reported trailing-twelve-month revenue of about ₹9.2B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of KRITINUT?
The net profit margin of Kriti Nutrients Limited is about 3.7%, meaning it keeps roughly 3.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Kriti Nutrients Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.